Wednesday, October 2, 2024

NIAID Funding News, October 2, 2024

NIH/NIAID Template Banner

October 2, 2024 NIAID Funding News

Read this full edition online at https://www.niaid.nih.gov/grants-contracts/funding-news?edition=2024-10-02

Feature Articles 

Happenings from the September Meeting of NIAID's Advisory Council

NIAID Director Dr. Jeanne Marrazzo shared remarks before NIAID's Advisory Council, as did Dr. Ted Piersen, Director of NIAID's Vaccine Research Center.

Opportunities and Resources

Propose to discover and develop novel therapeutics directed at intracellular HIV targets and eliminate viral proteins by mechanisms like protein degradation and targeting of viral RNA through inhibiting RNA processing as well as degradation.

This initiative funds federally recognized American Indian/Alaska Native (AI/AN) tribes, tribal colleges or universities, tribal health programs, or tribal organizations to support health-related research, research career enhancement, and research infrastructure enhancement activities.

Apply to organize a series of annual in-person scientific meetings, conferences, symposia, and workshops to advance innovations in therapeutic and chemical toxicology research.

In The News

Last week, NIH completed a major overhaul of its Grants & Funding website. You can watch a video tour for a summary of key changes to the site's organization and resources.

Join NIH policy experts for a webinar covering essential updates and ways in which the latest changes in NIH policies, systems, and resources might impact your institution's grants administration procedures.

Reminder of NIH Policy on Late Applications Caused by Weather Emergencies; Examine Data on Professional Degree Types in NIH's Grant Portfolio; NIH Revises Its Definition of Sexual and Gender Minority Populations

Advice Corner

How familiar are you with NIAID's solicitation and contract vocabulary? Test your knowledge by taking our quiz and pay attention to the explanations for each answer.

Reader Questions

New Funding Opportunities

  • NOT-AI-24-075, Notice of Special Interest (NOSI): Administrative Supplement for Primary Caregiver Technical Assistance Supplements (PCTAS) (Admin Supp, Clinical Trial Optional)
  • RFA-AI-24-065, Discovery and Development of Novel Therapeutics for Select Fungal Pathogens (R21/R33, Clinical Trial Not Allowed)

Find other announcements at NIAID Opportunities and Announcements.

Send suggestions or comments to deaweb@niaid.nih.gov.


This email was sent to edwardlorilla1986.paxforex@blogger.com using GovDelivery Communications Cloud on behalf of: National Institute of Allergy and Infectious Diseases · 5601 Fishers Lane · Bethesda, MD 20892 · 1-866-284-4107 GovDelivery logo

No comments:

Post a Comment

Nvidia to Crash 50%?

Do NOT Buy Nvidia, Apple, Microsoft, Meta, ...